Additionally, while the elevated PDGFB and TGFB signaling in patient samples is likely due to the stromal and immune cells (Fig. 6)41, it is possible activation of these signaling pathways could improve the efficiency of generating SA cells and neuroblastoma tumors. This evidence concerns the gene PDGFB and neuroblastoma.